tiprankstipranks
Trending News
More News >
Mannatech Inc (MTEX)
:MTEX
US Market
Advertisement

Mannatech (MTEX) AI Stock Analysis

Compare
69 Followers

Top Page

MTEX

Mannatech

(NASDAQ:MTEX)

Rating:43Neutral
Price Target:
$8.00
▲(5.54% Upside)
Mannatech's overall stock score is predominantly impacted by weak financial performance, characterized by declining revenue, negative profitability, and liquidity concerns. Technical analysis indicates a lack of market momentum, and the valuation metrics highlight significant challenges. Recent corporate events further add to operational uncertainty, although they are not weighted in the score due to redistribution.

Mannatech (MTEX) vs. SPDR S&P 500 ETF (SPY)

Mannatech Business Overview & Revenue Model

Company DescriptionMannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management products. The company primarily sells its products directly, as well as through e-commerce and network marketing channels. Mannatech, Incorporated was founded in 1993 and is headquartered in Flower Mound, Texas.
How the Company Makes MoneyMannatech generates revenue primarily through the sale of its health and wellness products, which are distributed via a direct selling model. This involves a network of independent sales associates who earn commissions by selling products directly to consumers and recruiting new associates. The company’s key revenue streams include its line of nutritional supplements, which are formulated with their proprietary glyconutrient technology, as well as skin care and weight-management products. Mannatech's earnings are significantly influenced by the size and productivity of its sales associate base, the effectiveness of its incentive programs, and its ability to innovate and market new products effectively. Additionally, the company occasionally enters into partnerships or strategic collaborations to expand its market reach and enhance its product offerings.

Mannatech Financial Statement Overview

Summary
Mannatech is experiencing significant financial challenges, with declining revenue, negative net income, and negative EBIT. The cash flow situation is concerning with negative operating cash flow, indicating inefficiencies. Despite a stable gross profit margin, the overall financial health is weak, requiring strategic improvements.
Income Statement
45
Neutral
Mannatech's income statement indicates a declining trend in revenue and profitability. The TTM (Trailing-Twelve-Months) shows negative net income of -$220,000 and a negative EBIT, reflecting struggles in operational efficiency. Gross profit margin remains stable at around 76.6% in TTM, but the net profit margin has turned negative due to a significant drop in revenue from $159.8 million in 2021 to $115.0 million in TTM. These challenges highlight issues in scaling operations profitably.
Balance Sheet
50
Neutral
The balance sheet shows a high level of liabilities compared to equity, with a debt-to-equity ratio of 0.67 in TTM, indicating moderate financial leverage. The equity ratio has decreased to 20.7% from 43.1% in 2020, showing a declining reliance on equity financing. The company maintains a cash position of $9.3 million, but the shrinking stockholders' equity from $24.4 million in 2021 to $7.6 million in TTM suggests potential liquidity concerns if liabilities continue to rise.
Cash Flow
40
Negative
Cash flow analysis reveals declining free cash flow, which turned negative at -$814,000 in TTM, despite positive developments in previous years. The operating cash flow has drastically declined from $10.8 million in 2021 to -$981,000 in TTM, raising concerns about cash generation from core operations. The operating cash flow to net income ratio is negative, indicating inefficiencies in converting profits into cash.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue117.87M131.96M137.21M159.76M151.41M
Gross Profit91.46M102.86M104.15M125.61M115.90M
EBITDA5.55M702.00K1.22M10.77M6.48M
Net Income2.49M-2.24M-4.49M9.84M6.26M
Balance Sheet
Total Assets36.06M41.21M49.13M59.63M65.34M
Cash, Cash Equivalents and Short-Term Investments11.40M7.73M13.78M24.18M22.21M
Total Debt6.69M5.73M6.21M339.00K758.00K
Total Liabilities27.44M30.72M34.95M35.21M39.36M
Stockholders Equity8.61M10.48M14.18M24.41M25.97M
Cash Flow
Free Cash Flow1.96M-3.12M-3.66M10.12M5.08M
Operating Cash Flow2.26M-2.37M-2.60M10.77M6.03M
Investing Cash Flow-285.00K-747.00K-1.06M-650.00K-947.00K
Financing Cash Flow1.96M-1.90M-4.33M-9.29M-9.92M

Mannatech Technical Analysis

Technical Analysis Sentiment
Negative
Last Price7.58
Price Trends
50DMA
9.04
Negative
100DMA
9.42
Negative
200DMA
10.03
Negative
Market Momentum
MACD
-0.25
Positive
RSI
39.72
Neutral
STOCH
13.83
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MTEX, the sentiment is Negative. The current price of 7.58 is below the 20-day moving average (MA) of 8.25, below the 50-day MA of 9.04, and below the 200-day MA of 10.03, indicating a bearish trend. The MACD of -0.25 indicates Positive momentum. The RSI at 39.72 is Neutral, neither overbought nor oversold. The STOCH value of 13.83 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MTEX.

Mannatech Risk Analysis

Mannatech disclosed 39 risk factors in its most recent earnings report. Mannatech reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Mannatech Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
$36.48M12.6426.24%7.56%11.91%25.93%
63
Neutral
$20.31B12.53-7.33%3.14%2.92%-10.02%
57
Neutral
$2.51M1.82-1.68%-9.25%-109.49%
55
Neutral
$16.51M2.5816.79%7.75%-21.61%
51
Neutral
$207.92M-70.44%-17.97%49.13%
43
Neutral
$15.59M8.92-2.44%-9.59%87.78%
41
Neutral
$54.12M-180.03%-19.83%22.76%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
MTEX
Mannatech
7.58
0.20
2.71%
UG
United-Guardian
7.94
-2.38
-23.06%
TANH
Tantech Holdings
1.81
-4.19
-69.83%
SKIN
Beauty Health
1.59
0.47
41.96%
GROV
Grove Collaborative Holdings
1.29
-0.05
-3.73%
TKLF
Yoshitsu Co. Ltd. Sponsored ADR
3.82
-2.35
-38.09%

Mannatech Corporate Events

Executive/Board ChangesBusiness Operations and Strategy
Mannatech COO Resignation Announced
Negative
Jul 24, 2025

On July 21, 2025, Mannatech, Incorporated announced that its Chief Operating Officer, Peter Griscom, has resigned, effective August 8, 2025. This resignation may impact the company’s operations and strategic direction as they transition leadership roles.

Executive/Board ChangesBusiness Operations and Strategy
Mannatech Promotes Peter Griscom to COO Role
Positive
Jun 26, 2025

On June 26, 2025, Mannatech announced the promotion of Peter Griscom to Chief Operating Officer, effective July 1, 2025. Griscom, who has extensive experience in the consumer goods space and direct selling channel, previously served as the senior vice president of global operations. His promotion is expected to enhance operational efficiencies and streamline processes, positively impacting the company’s future.

Executive/Board ChangesShareholder Meetings
Mannatech Approves Proposals at Annual Shareholders’ Meeting
Neutral
Jun 4, 2025

On June 3, 2025, Mannatech, Incorporated held its annual shareholders’ meeting where all proposals were approved by the shareholders. The meeting saw the election of J. Stanley Fredrick and Tyler J. Rameson as Class II directors, the ratification of BDO USA, P.C. as the independent public accounting firm, and advisory approvals on executive compensation and its voting frequency. Approximately 77.8% of the total shares were represented at the meeting, indicating strong shareholder engagement.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 01, 2025